GINO BIOW |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.851 USD | -92.70% |
|
+27.38% | 0.00% |
Presenter SpeechAnna Wagner (Executives)Hi, everyone. I'm Anna Marie Wagner. I'm the Senior Vi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Ginkgo Bioworks Holdings, Inc. operates as a horizontal platform for cell programming, providing end-to-end services for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Its segments include Cell Engineering and Biosecurity. The Cell Engineering consists of research and development services performed under collaboration and license agreements relating to its cell programming platform. Its cell programming platform includes two core assets: the Foundry, and Codebase. The Biosecurity segment consists of biomonitoring and bioinformatic testing products and services primarily provided to public health authorities. It also focuses on the design of next-generation cell therapies for autoimmune diseases. It uses its platform to develop and screen libraries of novel NK-specific and T-cell specific chimeric antigen receptor and switch receptor designs, which enable control and performance of immune cell-based therapies.
Calendar
2024-06-13
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +29.63% | 49.18B | |
| +0.64% | 42.11B | |
| +50.47% | 40.37B | |
| -5.26% | 28.85B | |
| +13.76% | 26.09B | |
| -22.82% | 18.71B | |
| +8.07% | 13.26B | |
| +32.27% | 12.32B | |
| -1.39% | 11.99B |
- Stock Market
- Equities
- DNA Stock
- DNA Stock
- News GINO BIOW
- Transcript : Ginkgo Bioworks, Inc., Soaring Eagle Acquisition Corp. - Pre Recorded M&A Call
